Q&A: AdvaMed CEO Discusses 2020 Priorities In Broad-Ranging Interview

Following closely on the heels of a medical device tax repeal win, AdvaMed CEO Scott Whitaker sat down with Medtech Insight to discuss how the industry advocacy group ended the Obamacare excise tax and what it has in store for 2020.